BALANCE SHEET COMPONENTS (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| BALANCE SHEET COMPONENTS |
|
| Schedule of reconciliation of cash and cash equivalents and restricted cash |
| | | | | | | | | June 30, 2026 | | June 30, 2025 | | | | (amounts, in thousands) | Cash and cash equivalents | | $ | 4,413 | | $ | 10,204 | Restricted cash | | | 1,522 | | | 1,522 | Total cash, cash equivalents, and restricted cash | | $ | 5,935 | | $ | 11,726 |
|
| Schedule of inventories - net |
| | | | | | | | | June 30, 2026 | | December 31, 2025 | | | | (amounts, in thousands) | Raw materials | | $ | 658 | | $ | 751 | Work in process | | | 985 | | | 1,014 | Finished goods | | | 2,043 | | | 3,528 | Inventories | | | 3,686 | | | 5,293 | Less reserve | | | — | | | (12) | Inventories - net | | $ | 3,686 | | $ | 5,281 |
|
| Schedule of property and equipment |
| | | | | | | | | | | | | | | | | Depreciation/ | | | | | | | | | Amortization | | | June 30, 2026 | | December 31, 2025 | | Period | | | | (amounts, in thousands) | | | Furniture and fixtures | | $ | 1,536 | | $ | 1,532 | | 7 years | Equipment and computers | | | 5,064 | | | 5,129 | | 3 to 7 years | Leasehold improvements | | | 6,304 | | | 6,308 | | Lesser of term of lease or estimated useful life | | | | 12,904 | | | 12,969 | | | Less accumulated depreciation and amortization | | | (5,732) | | | (5,146) | | | Property and equipment - net | | $ | 7,172 | | $ | 7,823 | | |
|
| Schedule of patents - net |
| | | | | | | | | June 30, 2026 | | December 31, 2025 | | | | (amounts, in thousands) | Patent applications pending | | $ | 1,117 | | $ | 1,356 | Patents issued | | | 3,298 | | | 3,298 | Less accumulated amortization of patents issued | | | (1,551) | | | (1,428) | Patents - net | | $ | 2,864 | | $ | 3,226 |
|
| Schedule of Patent amortization expense related to patents issued |
| | | | | | (amounts, in thousands) | Remainder of 2026 | | $ | 122 | 2027 | | | 240 | 2028 | | | 227 | 2029 | | | 227 | 2030 | | | 227 | Thereafter | | | 704 | Scheduled amortization of patents issued | | $ | 1,747 |
|
| Schedule of accrued expenses and other current liabilities |
| | | | | | | | | June 30, 2026 | | December 31, 2025 | | | | (amounts, in thousands) | Accrued salaries and commissions | | $ | 3,381 | | $ | 3,413 | Clinical studies | | | 651 | | | 522 | Deferred revenue and contract liabilities | | | 1,139 | | | 182 | Professional fees | | | 472 | | | 856 | Royalties | | | 558 | | | 271 | Goods received not invoiced | | | 95 | | | 150 | Other | | | 987 | | | 905 | Accrued expenses and other current liabilities | | $ | 7,283 | | $ | 6,299 |
|